Dr. Kim is Chief Executive Officer of the MiCo BioMed Co., Ltd., an innovative LabChip-technology based diagnostic company in Korea that generates various biochemical, immunological and molecular diagnostic products including COVID-19 detection kits and systems. He founded NanoBioSys Inc. in 2009 and invented a portable molecular diagnostic system to detect multiple infectious disease pathogens rapidly using an inexpensive disposable plastic microfluidic Lab-on-a-Chip (LabChip). He has been working with international organizations such as the UN, WHO and Institute of Pasteur. He currently leads his colleagues to develop a more efficient portable easy-to-use tele-diagnostic system for rapid detection, monitoring and controlling animal/food-borne diseases as well as human diseases on site. He and his colleagues are moving towards an innovative U-healthcare system to provide a healthier environment for the world. He received Ph.D. in Biological Sciences at Columbia University and worked for Harvard Medical School as a research faculty over 13 years.
For a reasonably open world
